Morrisville, NC – August 20, 2025 – Carolina Molecular and Flagship Biosciences have formed a strategic partnership to deliver enhanced tissue-to-data solutions for translational and clinical research programs. Under this collaboration, Carolina Molecular will perform all molecular testing services for Flagship Biosciences through our CLIA-certified, CAP-accredited laboratory.

This partnership combines Flagship Biosciences’ expertise in spatial biology, histopathology, and image analysis with Carolina Molecular’s comprehensive molecular testing capabilities—creating a seamless, full-service solution for pharmaceutical companies, biotechnology firms, and research institutions.

Together, the organizations will support clients with integrated services spanning tissue processing, spatial analysis, molecular profiling, and bioinformatics.